ReviewWomen's health (London, England)2016
Medical management of heavy menstrual bleeding.
Review in Women's health (London, England), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
31 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Cyclical progestogens for heavy menstrual bleeding.The Cochrane database of systematic reviews · 2019Pooled it
- Investigation of copper and oxidative stress levels in oral contraceptive users.BMC women's health · 2026Article
- Leveraging connections between family planning and nutrition to improve the health of women.BMJ global health · 2026Review
- Opportunities and challenges for integrating family planning and nutrition policies and programmes in Burkina Faso: a mixed-methods study.BMJ global health · 2026Article
- Efficacy and safety of an Ayurvedic Menohelp syrup in the management of heavy menstrual bleeding (menorrhagia): an open-label clinical study.Drugs in context · 2026Article
- Minimum Set of Investigations Required for Evaluation of Abnormal Uterine Bleeding in Low Resource Setting.Journal of pharmacy & bioallied sciences · 2025Article
- The effect of medroxyprogesterone acetate plus conjugated equine estrogens on lipoprotein(a) and apolipoprotein concentrations in postmenopausal women: a systematic review and meta-analysis of randomized controlled trials.Diabetology & metabolic syndrome · 2025Review
- Prevalence and risk factors of heavy menstrual bleeding in Africa: a narrative review.Annals of medicine and surgery (2012) · 2025Review
- Ayurveda Management of Menorrhagia (Raktapradara): Protocol for a Randomized Controlled Trial.JMIR research protocols · 2025Article
- Diagnosis and management of acute abnormal uterine bleeding during menacme.Clinics (Sao Paulo, Brazil) · 2025Review
- Management of Abnormal Uterine Bleeding Among Reproductive Age Group Women: A Cross-Sectional Study.Journal of clinical medicine · 2024Article
- The Menstrual Health Manager (MHM): A Resource to Reduce Discrepancies Between Science and Practice in Sport and Exercise.Sports medicine (Auckland, N.Z.) · 2024Article
- Association of heavy menstrual bleeding with cardiovascular disease in US female hospitalizations.BMC medicine · 2024Article
- The Multi-faceted Effects of COVID-19 on Female Reproductive Health: An Updated Narrative Review.Cureus · 2024Review
- Efficacy of a vaginal suppository formulation prepared withFrontiers in pharmacology · 2024Article
- Effect of norethisterone dose and duration in the management of abnormal uterine bleeding: a narrative review and case report.Drugs in context · 2024Review
- Environmental Exposure to Emerging Alternatives of Per- and Polyfluoroalkyl Substances and Polycystic Ovarian Syndrome in Women Diagnosed with Infertility: A Mixture Analysis.Environmental health perspectives · 2023Article
- Article
- Measurement of changes in uterine and fibroid volume during treatment of heavy menstrual bleeding (HMB).Human reproduction open · 2023Article
- Comparative study of the levonorgestrel intrauterine system and laparoscopic hysterectomy for the treatment of heavy menstrual bleeding in enlarged uteri.Einstein (Sao Paulo, Brazil) · 2023Observational
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Women with benign heavy menstrual bleeding have the choice of a number of medical treatment options to reduce their blood loss and improve quality of life. The role of the clinician is to provide information to facilitate women in making an appropriate choice. Unfortunately, many options can be associated with hormonal side effects, prevention of fertility and lack of efficacy, leading to discontinuation and progression to surgical interventions. Herein, we discuss the various options currently available to women, including antifibrinolytics, nonsteroidal anti-inflammatory preparations, oral contraceptive pills and oral, injectable and intrauterine progestogens. In addition, we describe the more novel option of selective progesterone receptor modulators and their current benefits and limitations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.